Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA BSE: 524715

₹1840

(1.13%)

Sat, 12 Sept 2026, 10:15 pm

MTF 5xInvest in Sun Pharmaceutical Industries Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)441947.11

PE Ratio36.50

Dividend0.86

Health Technology

Pharmaceuticals: Major

24.5K

Sun Pharmaceutical Industries News

Sun Pharma Q1 Results: Net Profit Up, US Sales Slip

Sun Pharmaceutical Q1 consolidated net profit rose to ₹29B vs ₹23B YoY. Revenue came in at ₹153B vs ₹138B YoY, while US sales declined 10% to USD 427M.

31 Jul 2026

companies

Sun Pharma wins Brazil nod for semaglutide

Sun Pharmaceutical Industries Limited has secured regulatory approval from Brazil's ANVISA to manufacture and market semaglutide for type 2 diabetes. The company plans a rapid launch with partner Hypera Pharma in the USD 413 million market.

29 Jul 2026

companies

Sun Pharma Sees ₹198.88 Cr NSE Block Trade

Sun Pharmaceutical recorded a block trade on NSE worth ₹198.88 crores, involving approximately 1,003,116 shares at ₹1982.60 per share.

28 Jul 2026

equity-markets

Philogen Re-Submits NIDLEGY™ Application to EMA

Sun Pharmaceutical's partner Philogen has re-submitted the NIDLEGY™ marketing application to the European Medicines Agency for the treatment of advanced melanoma.

27 Jul 2026

companies

Sun Pharma Sees ₹438.09 Cr Block Trade on NSE

Sun Pharmaceutical recorded a block trade of ₹438.09 crores on the NSE, involving approximately 2,242,462 shares at a price of ₹1953.60 per share.

27 Jul 2026

equity-markets

Showing 1–5 of 134

Rows per page:

Market Current News

Injecto Polymers IPO Day 1: Subscription at 0.06x

Injecto Polymers IPO sees modest demand on Day 1 with total subscription at 0.06x. Retail leads with 0.08x, while QIB remains flat. Issue closes on September 16.

11 Sept 2026

ipo

NSE IPO DRHP: ₹16,601 Cr Revenue, 99.79% Market Share

National Stock Exchange files DRHP for pure OFS of 12.64 crore shares. India's largest exchange reports FY26 revenue of ₹16,601 Cr and PAT of ₹10,302 Cr with dominant market share.

11 Sept 2026

ipo

Vinod Texworld IPO Day 3: Fully Subscribed

Vinod Texworld IPO crosses 1x mark on Day 3 with Retail driving demand. Total subscription stands at 1.16x as QIB remains flat. Check full subscription details.

11 Sept 2026

ipo

Asset Reconstruction Company IPO Day 3: QIB demand surges 588%

The Asset Reconstruction Company IPO is fully subscribed on Day 3 with a total subscription of 1.57x. QIB category saw a massive jump of 588% intraday, while NII (bHNI) leads at 2.88x.

11 Sept 2026

ipo

Century Business Media IPO Day 1: Weak Start

Century Business Media IPO opens on Day 1 with a subscription of just 0.08x. NII (bHNI) leads with 0.46x, while QIB and Retail show minimal interest. Check full details.

11 Sept 2026

ipo

Showing 1–5 of 94219

Rows per page: